Nach § 5 TMG ist für den Inhalt dieser Webseite verantwortlich:


Sciomics GmbH
Im Neuenheimer Feld 583
69120 Heidelberg

Vertreten durch Dr. Christoph Schröder



Telefon: +49 (0) 6221 4294830
Telefax: +49 (0) 6221 4294834
E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.



Eintragung im Handelsregister am Registergericht Mannheim unter der Registernummer HRB 716969.



Umsatzsteuer-Identifikationsnummer gemäß §27 a Umsatzsteuergesetz: DE289272460


Urheberrecht und Haftung

Die Verwendung von Texten, Textteilen oder Bildern dieser Homepage bedarf unserer ausdrücklichen vorherigen schriftlichen Zustimmung.

Trotz sorgfältiger inhaltlicher Kontrolle übernehmen wir keine Haftung für die Inhalte externer Links. Für den Inhalt der verlinkten Seiten sind ausschließlich deren Betreiber verantwortlich.





Meeting | Sciomics @ Analytica 2018

| April 10-13 2018 | Meet the Sciomics' team at Analytica in Munich. Visit our booth A3.333-4 to learn more about our protein and post-translational modificaftion profiling services.

New article | Role of Corneal Stromal Cells on Epithelial Cell Function during Wound Healing

| February 2018 | Researchers at Rostock University Medical Center published an article on the role of Corneal Stromal Cells on Epithelial Cell Function during Wound Healing in the International Journal of Molecular Sciences.

> Customer Testimonial Bhavani Kowtharapu:

"I am really happy with service of Sciomics. Very friendly team and really fast service and we have the results in our hand including bioinformatics analysis within 2 weeks. Thank you Sciomics team."

> More testimonials

Research | Participation in collaborative clinical studies for the treatment of MCDS

| January 2018 | The multinational consortium MCDS-therapy has been granted 5.7 Million Euro by the European Commission for the development of novel therapeutic approaches in rare skeletal disorders. Sciomics' expertise with the antibody microarray technology herein serves as a valuable tool for biomarker identification and personalized treatment monitoring. > Press release

New article | Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells

| January 2018 | A scioDiscover protein microarray study contributed to an article in Cell Reports. In this study Gerard Ruiz-Babot et al. analysed a donor specific reprogramming of cells.

Customer testimonial Leonardo Guasti, PhD (senior author):

This has undoubtedly opened new avenues in our research. We have found the Sciomics team to be extremely helpful and efficient during the whole process, from advising the best strategy to the final interpretation of results.

> More testimonials

A glas full of hope | Ein Glas Hoffnung

| January 2018 | Article on the StartUp Sciomics and our antibody microarray platform by our partner SCHOTT nexterion.

> English version "A glass full of hope"

> Deutsche Version "Ein Glas Hoffnung"